InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-14.7%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Centea Scott, SVP/GM, VIT. Officer active across 1 company, notably Angiodynamics INC. In total, 16 reports have been logged. History available since 14 July 2021. The latest transaction was disclosed on 19 July 2023 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations16 total
7,539 shares0Common StockSEC:0001140361-23-044837:0
3,415 shares0Common StockSEC:0001140361-23-036319:0
333 shares@ US$8.740.6% of flowCommon StockSEC:0001140361-23-036118:0
255 shares@ US$8.650.4% of flowCommon StockSEC:0001140361-23-036118:1
10,588 shares0Common StockSEC:0001140361-23-035727:0
517 shares@ US$9.631.0% of flowCommon StockSEC:0001140361-23-035084:0
351 shares@ US$9.560.7% of flowCommon StockSEC:0001140361-23-035084:1
3,705 shares0Common StockSEC:0001567619-22-014365:0
953 shares@ US$29.370.0054% mcap5.5% of flowCommon StockSEC:0001567619-21-019404:0
953 shares@ US$29.375.3% of flowCommon StockSEC:0001567619-21-019404
12,000 shares@ US$16.770.039% mcap39.8% of flowCommon StockSEC:0001567619-21-018407:0
12,000 shares@ US$16.7738.8% of flowCommon StockSEC:0001567619-21-018407
419 shares@ US$26.102.1% of flowCommon StockSEC:0001567619-21-014064
419 shares@ US$26.100.0021% mcap2.1% of flowCommon StockSEC:0001567619-21-014064:0
500 shares@ US$26.432.5% of flowCommon StockSEC:0001567619-21-013923
500 shares@ US$26.430.0025% mcap2.6% of flowCommon StockSEC:0001567619-21-013923:0
16 of 16 declarations
About Centea Scott
Scott Centea is the SVP/GM, VIT at Angiodynamics Inc, a company specializing in medical devices. He is responsible for managing operations and product development strategy for this division.
